Raisa S Pompe1, Zhe Tian2, Felix Preisser3, Pierre Tennstedt3, Burkhard Beyer3, Uwe Michl3, Markus Graefen3, Hartwig Huland3, Pierre I Karakiewicz2, Derya Tilki4. 1. Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. 2. Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. 3. Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. 4. Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. Electronic address: d.tilki@uke.de.
Abstract
BACKGROUND: Results from population-based studies and the Prostate Testing for Cancer and Treatment trial reported worse urinary continence (UC) and erectile function (EF) for radical prostatectomy (RP) patients compared with their radiation or active surveillance counterparts. OBJECTIVE: To investigate functional outcomes for patients undergoing RP in a high-volume center. DATA, SETTING, AND PARTICIPANTS: A total of 8573 consecutive RP patients (2008-2012) were analyzed. INTERVENTION: RP. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Standardized questionnaires assessing EF, UC, and quality of life (QoL), were completed at baseline and annually thereafter. UC was defined as use of 0 or 1 safety pad/d, whereas the regular use of 1 pad/d was considered incontinent. EF was defined as ≥3 points in the International Index of Erectile Function question two. QoL was assessed using the EORTC-QLQ-C30 Global Health/QoL item. Statistics relied on comparison of means and proportions. RESULTS AND LIMITATIONS: EF and UC rates significantly decreased after RP. Overall, 12-mo, 24-mo, and 36-mo EF rates were 45%, 51%, and 53%, but reached up to 65.7% in preoperatively potent patients with bilateral nerve sparing. At 36 mo, 13% reported problems in their partnership. However, at the same time point, 77% were satisfied with their sexual intercourse. UC rates were 89.1%, 91.3%, and 89.0% at 12-mo, 24-mo, and 36-mo postoperatively. Mean EORTC-QLQ-C30 scores ranged from 74 to 79 and remained constant compared to baseline. CONCLUSIONS: Although varying definitions hinder direct comparisons to other studies, functional outcomes seemed favorable for patients undergoing RP in a high-volume center and most patients reported excellent QoL. PATIENT SUMMARY: Results of functional outcomes (urinary continence and potency) after radical prostatectomy are better in a high-volume center compared with those obtained from population-based data, and most patients report excellent quality of life after radical prostatectomy.
BACKGROUND: Results from population-based studies and the Prostate Testing for Cancer and Treatment trial reported worse urinary continence (UC) and erectile function (EF) for radical prostatectomy (RP) patients compared with their radiation or active surveillance counterparts. OBJECTIVE: To investigate functional outcomes for patients undergoing RP in a high-volume center. DATA, SETTING, AND PARTICIPANTS: A total of 8573 consecutive RP patients (2008-2012) were analyzed. INTERVENTION: RP. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Standardized questionnaires assessing EF, UC, and quality of life (QoL), were completed at baseline and annually thereafter. UC was defined as use of 0 or 1 safety pad/d, whereas the regular use of 1 pad/d was considered incontinent. EF was defined as ≥3 points in the International Index of Erectile Function question two. QoL was assessed using the EORTC-QLQ-C30 Global Health/QoL item. Statistics relied on comparison of means and proportions. RESULTS AND LIMITATIONS: EF and UC rates significantly decreased after RP. Overall, 12-mo, 24-mo, and 36-mo EF rates were 45%, 51%, and 53%, but reached up to 65.7% in preoperatively potent patients with bilateral nerve sparing. At 36 mo, 13% reported problems in their partnership. However, at the same time point, 77% were satisfied with their sexual intercourse. UC rates were 89.1%, 91.3%, and 89.0% at 12-mo, 24-mo, and 36-mo postoperatively. Mean EORTC-QLQ-C30 scores ranged from 74 to 79 and remained constant compared to baseline. CONCLUSIONS: Although varying definitions hinder direct comparisons to other studies, functional outcomes seemed favorable for patients undergoing RP in a high-volume center and most patients reported excellent QoL. PATIENT SUMMARY: Results of functional outcomes (urinary continence and potency) after radical prostatectomy are better in a high-volume center compared with those obtained from population-based data, and most patients report excellent quality of life after radical prostatectomy.
Authors: Anne Holck Storås; Martin G Sanda; Olatz Garin; Peter Chang; Dattatraya Patil; Catrina Crociani; Jose Francisco Suarez; Milada Cvancarova; Jon Håvard Loge; Sophie D Fosså Journal: Asian J Urol Date: 2019-08-19
Authors: Ursula Kahl; Sarah Callsen; Stefanie Beck; Hans Pinnschmidt; Franziska von Breunig; Alexander Haese; Markus Graefen; Christian Zöllner; Marlene Fischer Journal: Health Qual Life Outcomes Date: 2021-02-25 Impact factor: 3.186
Authors: Benedikt Hoeh; Felix Preisser; Mike Wenzel; Clara Humke; Clarissa Wittler; Jan L Hohenhorst; Maja Volckmann-Wilde; Jens Köllermann; Thomas Steuber; Markus Graefen; Derya Tilki; Pierre I Karakiewicz; Andreas Becker; Luis A Kluth; Felix K H Chun; Philipp Mandel Journal: Curr Oncol Date: 2021-11-15 Impact factor: 3.677
Authors: Alexander Philippi; Philipp Mandel; Jan L Hohenhorst; Mike Wenzel; Clara Humke; Clarissa Wittler; Jens Köllermann; Thomas Steuber; Markus Graefen; Derya Tilki; Pierre I Karakiewicz; Felix Preisser; Andreas Becker; Luis A Kluth; Felix K H Chun; Benedikt Hoeh Journal: Cent European J Urol Date: 2022-06-04
Authors: Eelco R P Collette; Sjoerd O Klaver; Birgit I Lissenberg-Witte; Dies van den Ouden; Reindert J A van Moorselaar; André N Vis Journal: J Robot Surg Date: 2020-09-15
Authors: Benedikt Hoeh; Mike Wenzel; Matthias Müller; Clarissa Wittler; Eva Schlenke; Jan L Hohenhorst; Jens Köllermann; Thomas Steuber; Markus Graefen; Derya Tilki; Simon Bernatz; Pierre I Karakiewicz; Felix Preisser; Andreas Becker; Luis A Kluth; Philipp Mandel; Felix K H Chun Journal: Diagnostics (Basel) Date: 2022-03-13